Guardian Pharmacy Services, Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Guardian Pharmacy Services, Inc. (GRDN) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $35.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-06
- Guardian Pharmacy Services, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $22.12M, a 150.61% increase year-over-year.
- Guardian Pharmacy Services, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $13.54M, a 46.06% increase year-over-year.
- Guardian Pharmacy Services, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $21.27M, a 79.59% increase year-over-year.
- Guardian Pharmacy Services, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $9.59M.
- Guardian Pharmacy Services, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $48.96M.
- Guardian Pharmacy Services, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$71.03M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $35.66M 10-Q · filed 2026-08-06 | $56.93M derived: sum of 3 quarters · filed 2026-08-06 | $66.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $13.54M 10-Q · filed 2026-05-06 | $34.81M derived: sum of 2 quarters · filed 2026-05-06 | $44.40M derived: sum of 3 quarters · filed 2026-05-06 | $53.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $21.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $30.86M derived: sum of 2 quarters · filed 2026-03-11 | $39.69M derived: sum of 3 quarters · filed 2026-08-06 | $48.96M 10-K · filed 2026-03-11 |
| 2025-09-30 | $9.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $18.42M derived: sum of 2 quarters · filed 2026-08-06 | $27.69M 10-Q · filed 2025-11-10 | $39.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $8.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $18.10M 10-Q · filed 2026-08-06 | $29.94M derived: sum of 3 quarters · filed 2026-08-06 | -$75.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $9.27M 10-Q · filed 2026-05-06 | $21.11M derived: sum of 2 quarters · filed 2026-05-06 | -$84.70M derived: sum of 3 quarters · filed 2026-05-06 | -$68.86M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $11.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | -$93.98M derived: sum of 2 quarters · filed 2026-03-11 | -$78.13M derived: sum of 3 quarters · filed 2026-03-11 | -$71.03M 10-K · filed 2026-03-11 |
| 2024-09-30 | -$105.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$89.97M derived: sum of 2 quarters · filed 2025-11-10 | -$82.87M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $15.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $22.94M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $7.09M 10-Q · filed 2025-05-12 | |||
| 2023-09-30 | $23.16M 10-Q · filed 2024-11-12 |